Works matching DE "CYTOCHROME P-450 CYP2C19"

Results: 320

In This Issue.

Published in:: Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 2, p. 281, doi. 10.1002/cpt.3743
Publication type:: Article

Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y<sub>12</sub> Inhibitor Prescribing.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 2, p. 470, doi. 10.1002/cpt.3698

By:

Springer, Ashley N.;
Alicea, Leah A.;
Gafari, Yemi;
Smith, Tayler B.;
Lynch, Sheryl;
Breman, Amy M.;
Hodge, Jennelle C.;
Pratt, Victoria M.;
Powell, Nicholas R.;
Kreutz, Rolf P.;
Kobold, Daniel P.;
Eadon, Michael T.;
Tillman, Emma M.;
Shugg, Tyler;
Skaar, Todd C.

Publication type:

Article

Prospective DDI Risk Assessment of Vicasinabin with PBPK Modeling by Integrating In Vitro Data.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 2, p. 428, doi. 10.1002/cpt.3686

By:

Umehara, Kenichi;
Parrott, Neil;
Günther, Andreas;
Bogman, Katrijn

Publication type:

Article

The orexin 1-selective receptor antagonist nivasorexant is a time-dependent inhibitor of CYP2C19 and CYP3A4.

Published in:

Xenobiotica, 2025, v. 55, n. 4, p. 296, doi. 10.1080/00498254.2025.2513321

By:

Treiber, Alexander;
Drouet, Fabienne;
Seeland, Swen;
Willecke, Florian;
Williams, Jodi T.;
Aissaoui, Hamed;
Berger, Benjamin;
Delahaye, Stephane

Publication type:

Article

CYP2C19 variability and clinical outcomes of clopidogrel, proton pump inhibitors, and voriconazole in Southeast Asia: a systematic review and meta-analysis.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1572886

By:

Hardi, Harri;
Barinda, Agian Jeffilano;
Mahata, Liganda Endo;
Fitrianti, Zahra

Publication type:

Article

Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine.

Published in:

Journal of Personalized Medicine, 2025, v. 15, n. 6, p. 245, doi. 10.3390/jpm15060245

By:

Díaz-Villamarín, Xando;
Martínez-Pérez, María;
Nieto-Sánchez, María Teresa;
Fernández-Varón, Emilio;
Torres-García, Alicia;
Blancas, Isabel;
Cabeza-Barrera, José;
Morón, Rocío

Publication type:

Article

Exploring the Pharmacogenetic Landscape: Identification of Clinically Relevant Genotypes by a Nation-Wide Medical Testing Laboratory in Romania.

Published in:

Pharmaceuticals (14248247), 2025, v. 18, n. 6, p. 898, doi. 10.3390/ph18060898

By:

Pop, Cristina;
Curici, Antoanela;
Voștinaru, Oliviu;
Apan, Anamaria;
Piciu, Andra;
Silaghi, Cristina Alina;
Silaghi, Horatiu;
Popa, Stefan Lucian;
Dorobanțu, Florica Ramona;
Mogoșan, Cristina

Publication type:

Article

Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated Patients.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3992, doi. 10.3390/jcm10173992

By:

Olie, Renske H.;
Hensgens, Rachelle R. K.;
Wijnen, Petal A. H. M.;
Veenstra, Leo F.;
de Greef, Bianca T. A.;
Vries, Minka J. A.;
van der Meijden, Paola E. J.;
ten Berg, Jurriën M.;
ten Cate, Hugo;
Bekers, Otto;
Henskens, Yvonne M. C.

Publication type:

Article

Drug–Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3964, doi. 10.3390/jcm10173964

By:

Suzuki, Yoshiharu;
Yoshihashi, Takuya;
Takahashi, Kazuhiro;
Furuya, Kinji;
Ohkohchi, Nobuhiro;
Oda, Tatsuya;
Homma, Masato

Publication type:

Article

Still a dilemma! Are vonoprazan and esomeprazole attenuating the antiplatelet function of clopidogrel when taken concomitantly? A systematic review and meta-analysis.

Published in:

Egyptian Journal of Internal Medicine, 2025, v. 37, n. 1, p. 1, doi. 10.1186/s43162-025-00429-6

By:

Youssef, Eman;
Gamal, Aliaa;
Youssef, Hagar

Publication type:

Article

Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China.

Published in:

Genetics Research, 2022, p. 1, doi. 10.1155/2022/1901256

By:

Chang, Rong;
Zhou, Wenqin;
Ye, Yi;
Zhang, Xiaofei;
Liu, Yanmin;
Wu, Jinchun;
Mazziotta, Chiara

Publication type:

Article

Determining The Enhancing Effects Of PCR Additives On Long- Range PCR.

Published in:

2022

By:

Karunanathie, Harsheni;
Eng Wee Chua

Publication type:

Abstract

Comparative in vitro assessment of CYP2C19 inhibition by ilaprazole and conventional proton pump inhibitors using a high throughput fluorometric assay.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-02872-5

By:

Priyadharshini, A.;
Vijayakumar, T. M.;
Damodharan, N.;
Vasanth, K. M.;
Elaiyaraja, Arun

Publication type:

Article

Analysis of the effect of CYP2C19 gene properties on the anti-platelet aggregation of clopidogrel after carotid artery stenting under network pharmacology.

Published in:

BMC Pharmacology & Toxicology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s40360-024-00750-w

By:

Li, Pengfei;
Cao, Mengying;
Liu, Ling;
Chen, Long;
Liang, Shuang;
Wang, Youbin

Publication type:

Article

Meta‐Analysis of Noncompartmental Pharmacokinetic Parameters to Evaluate the Impact of CYP2C19 and CYP2C9 Genetic Polymorphisms on Abrocitinib Exposure.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 10, p. 1098, doi. 10.1002/cpdd.1465

By:

Fostvedt, Luke;
Liu, Jian;
Wang, Xiaoxing;
Li, Yinhua;
Johnson, Jillian;
Wood, Linda;
Dowty, Martin;
Malhotra, Bimal;
Valdez, Hernan;
Nicholas, Timothy;
Xue, Wei

Publication type:

Article

Evaluation of Drug–Drug Interaction Potential of Enarodustat (JTZ‐951) Using a Cytochrome P450 Probe Cocktail.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 7, p. 667, doi. 10.1002/cpdd.1263

By:

Pai, Sudhakar M.;
Yamada, Hiroyuki;
Murata, Hiroyuki

Publication type:

Article

Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism.

Published in:

Clinical Pharmacology in Drug Development, 2023, v. 12, n. 6, p. 553, doi. 10.1002/cpdd.1255

By:

Lee, Caroline A.;
Oh, D. Alexander;
Tang, Yong;
Yi, Ping;
Bashir, Mohammad;
English, Stephen;
Croft, Marie;
Blackburn, Anthony;
Bloom, Steve;
Gilder, Kye;
Grundy, John S.

Publication type:

Article

Influence of CYP2C19 Polymorphisms on the Pharmacokinetics of Omeprazole in Elderly Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1469, doi. 10.1002/cpdd.966

By:

Na, Joo Young;
Jeon, Inseung;
Yoon, Jangsoo;
Choi, Yewon;
Yoon, Seo Hyun;
Yu, Kyung‐Sang;
Chung, Jae‐Yong

Publication type:

Article

Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 9, p. 1007, doi. 10.1002/cpdd.956

By:

Desrivot, Julie;
Van Kaem, Tim;
Allamassey, Lisa;
Helmer, Eric

Publication type:

Article

In vivo effects of bempedoic acid on microdosed CYP probe drugs.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1544956

By:

Stoll, Felicitas;
Amato, Salvatore;
Burhenne, Jürgen;
Blank, Antje

Publication type:

Article

Association between CYP2C19 polymorphism and proton pump inhibitors adverse drug reactions: a narrative review.

Published in:

2025

By:

Ibrahim, Asmaa;
Yusuff, Kazeem;
Awaisu, Ahmed;
Elewa, Hazem

Publication type:

Literature Review

Impact of fresh grape juice on the pharmacokinetics of omeprazole: results of a food–drug interaction study.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1467805

By:

Iftikhar, Tayyaba;
Iqbal, Zafar;
Shah, Yasar;
Khan, Nauman Rahim;
Abbas, Muhammad;
Shehzad, Omer;
Hadi, Fazal;
Sardar, Haseeba;
Abusharha, Ali;
Daglia, Maria;
Khan, Haroon

Publication type:

Article

Comparing commercial pharmacogenetic testing results and recommendations for antidepressants with established CPIC guidelines.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1500235

By:

Nguyen, Tiffany T.;
Leary, Emili J. W.;
Lee, Joshua T.;
Shukla, Sanjay K.;
Griesbach, Sara A.

Publication type:

Article

Consideration of the Medical Economics of Cardiac Genetics, Focusing on the Cost-Effectiveness of P2Y12 Inhibitor Selection Based on the CYP2C19 Loss-of-Function Allele: A Semi-Systematic Review.

Published in:

Cardiogenetics, 2024, v. 14, n. 2, p. 59, doi. 10.3390/cardiogenetics14020005

By:

Takura, Tomoyuki

Publication type:

Article

Ticagrelor-Aspirin Versus Clopidogrel-Aspirin Among Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 Trial.

Published in:

2022

By:

Wang, Anxin;
Xie, Xuewei;
Tian, Xue;
Johnston, S. Claiborne;
Li, Hao;
Bath, Philip M.;
Zuo, Yingting;
Jing, Jing;
Lin, Jinxi;
Wang, Yilong;
Zhao, Xingquan;
Li, Zixiao;
Jiang, Yong;
Liu, Liping;
Meng, Xia;
Wang, Yongjun

Publication type:

journal article

Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER<sup>+</sup> breast cancer.

Published in:

Egyptian Journal of Medical Human Genetics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s43042-022-00332-7

By:

Boucenna, Amira;
Boudaoud, Khadidja;
Hireche, Ahmed;
Rezgoune, Mohamed Larbi;
Abadi, Noureddine;
Filali, Taha;
Satta, Dalila

Publication type:

Article

The efficacy of clopidogrel in preventing recurrent cardiovascular events among Arab population carrying different CYP2C19 mutations: systematic review and meta-analysis.

Published in:

Egyptian Journal of Medical Human Genetics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s43042-022-00313-w

By:

Alkattan, Abdullah N.;
Radwan, Nashwa M.;
Mahmoud, Nagla E.;
Alfaleh, Amjad F.;
Alfaifi, Amal H.;
Alabdulkareem, Khaled I.

Publication type:

Article

Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population.

Published in:

PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0263137

By:

Goljan, Ewa;
Abouelhoda, Mohammed;
ElKalioby, Mohamed M.;
Jabaan, Amjad;
Alghithi, Nada;
Meyer, Brian F.;
Monies, Dorota

Publication type:

Article

Pharmacogenomics knowledge within Neurology: A brief survey amongst physicians.

Published in:

Neurology Asia, 2023, v. 28, n. 4, p. 943, doi. 10.54029/2023xfs

By:

NARASIMHALU, Kaavya;
SOO, Joel;
Jia Yi SHEN;
Pei Shieen WONG

Publication type:

Article

Differential effect of clopidogrel and ticagrelor on leukocyte count in relation to patient characteristics, biomarkers and genotype: a PLATO substudy.

Published in:

Platelets, 2022, v. 33, n. 3, p. 425, doi. 10.1080/09537104.2021.1934667

By:

Nelson, Thomas A.;
Parker, William A.E.;
Ghukasyan Lakic, Tatevik;
Westerbergh, Johan;
James, Stefan K.;
Siegbahn, Agneta;
Becker, Richard C.;
Himmelmann, Anders;
Wallentin, Lars;
Storey, Robert F.

Publication type:

Article

Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis.

Published in:

Platelets, 2021, v. 32, n. 5, p. 591, doi. 10.1080/09537104.2020.1792871

By:

Biswas, Mohitosh;
Kali, Most. Sumaiya Khatun;
Biswas, Tapash Kumar;
Ibrahim, Baharudin

Publication type:

Article

The efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy compared with conventional antiplatelet therapy in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Published in:

Platelets, 2020, v. 31, n. 8, p. 971, doi. 10.1080/09537104.2020.1780205

By:

Lyu, Si-Qi;
Yang, Yan-Min;
Zhu, Jun;
Wang, Juan;
Wu, Shuang;
Zhang, Han;
Shao, Xing-Hui;
Ren, Jia-Meng

Publication type:

Article

The Utility of CYP2D6 and CYP2C19 Variants to Guide Pharmacological Treatment in Complex Unipolar Major Depression: A Pilot Longitudinal Study.

Published in:

Psychiatric Quarterly, 2023, v. 94, n. 3, p. 435, doi. 10.1007/s11126-023-10044-9

By:

Ramaraj, Reshma;
Al-Mahayri, Zeina N.;
Saleous, Reema;
Abdel Aziz, Karim;
Al-Mugaddam, Fadwa;
Al-Sabousi, Mouza;
Alhassani, Aysha;
Ahbabi, Noura Ali Al;
Stip, Emmanuel;
Patrinos, George P.;
Ali, Bassam R.;
Arnone, Danilo

Publication type:

Article

Assessing Clinical Utility of Pharmacogenetic Testing in the Military Health System.

Published in:

Military Medicine, 2024, v. 189, n. 1/2, p. e198, doi. 10.1093/milmed/usad254

By:

Hellwig, Lydia D;
Turner, Clesson;
Olsen, Cara;
Libbus, Joya;
Markos, Bethelhem;
Koehlmoos, Tracey;
Haigney, Mark;
De Castro, Mauricio;
Saunders, David

Publication type:

Article

Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System.

Published in:

2022

By:

Selig, Daniel J;
Livezey, Jeffrey R;
Chin, Geoffrey C;
DeLuca, Jesse P;
II, Walter O Guillory;
Kress, Adrian T;
Oliver, Thomas O;
Por, Elaine D;
Guillory Ii, Walter O

Publication type:

journal article

Changes in S‐Citalopram Plasma Concentrations Across Pregnancy and Postpartum.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 118, n. 1, p. 106, doi. 10.1002/cpt.3642

By:

Stika, Catherine S.;
Avram, Michael J.;
George, Alfred L.;
Yang, Amy;
Ciolino, Jody D.;
Jeong, Hyunyoung;
Venkataramanan, Raman;
Caritis, Steve N.;
Costantine, Maged M.;
Wisner, Katherine L.

Publication type:

Article

Identification of Genetic Variants Associated with Pravastatin and Pitavastatin Pharmacokinetics.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 6, p. 1763, doi. 10.1002/cpt.3623

By:

Mykkänen, Anssi J. H.;
Tarkiainen, E. Katriina;
Taskinen, Suvi;
Neuvonen, Mikko;
Paile‐Hyvärinen, Maria;
Lilius, Tuomas O.;
Tapaninen, Tuija;
Backman, Janne T.;
Tornio, Aleksi;
Niemi, Mikko

Publication type:

Article

A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 6, p. 1732, doi. 10.1002/cpt.3610

By:

Aurinsalo, Laura;
Lapatto‐Reiniluoto, Outi;
Kurkela, Mika;
Neuvonen, Mikko;
Kiiski, Johanna I.;
Niemi, Mikko;
Tornio, Aleksi;
Backman, Janne T.

Publication type:

Article

Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 5, p. 1313, doi. 10.1002/cpt.3552

By:

Yang, Guang;
Alarcon, Cristina;
Chanfreau, Catherine;
Lee, Norman H.;
Friedman, Paula;
Nutescu, Edith;
Tuck, Matthew;
O'Brien, Travis;
Gong, Li;
Klein, Teri E.;
Chang, Kyong‐Mi;
Tsao, Philip S.;
Meltzer, David O.;
Lynch, Julie A.;
Tuteja, Sony;
Perera, Minoli A.

Publication type:

Article

American Society for Clinical Pharmacology and Therapeutics.

Published in:: Clinical Pharmacology & Therapeutics, 2025, v. 117, p. S5, doi. 10.1002/cpt.3607
Publication type:: Article

Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically‐Based Pharmacokinetic Modeling and Clinical Observation.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 826, doi. 10.1002/cpt.3537

By:

Jang, Yoo Jin;
Kim, Doh Kwan;
Lim, Shinn‐Won;
Hong, Eunjin

Publication type:

Article

French‐Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Clinical Use of Mavacamten.

Published in:

Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 387, doi. 10.1002/cpt.3502

By:

Lebreton, Louis;
Boyer, Jean‐Christophe;
Lafay‐Chebassier, Claire;
Hennart, Benjamin;
Baklouti, Sarah;
Cunat, Séverine;
Vilquin, Paul;
Medard, Yves;
Gautier‐Veyret, Elodie;
Laffitte‐Redondo, Clara;
Verstuyft, Céline;
Ait Tayeb, Abd El Kader;
Haufroid, Vincent;
Wils, Julien;
Lamoureux, Fabien;
Evrard, Alexandre;
Davaze‐Schneider, Julie;
Ben‐Sassi, Mouna;
Picard, Nicolas;
Quaranta, Sylvie

Publication type:

Article

Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1121, doi. 10.1002/cpt.3378

By:

Abouir, Kenza;
Exquis, Nadia;
Gloor, Yvonne;
Daali, Youssef;
Samer, Caroline Flora

Publication type:

Article

Assessing the Performance of In silico Tools and Molecular Dynamics Simulations for Predicting Pharmacogenetic Variant Impact.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1082, doi. 10.1002/cpt.3348

By:

AlSaeed, Maryam Jamal;
Ramdhan, Peter;
Malave, Jean Gabriel;
Eljilany, Islam;
Langaee, Taimour;
McDonough, Caitrin W.;
Seabra, Gustavo;
Li, Chenglong;
Cavallari, Larisa H.

Publication type:

Article

Association of Pharmacogenomic Phenotypes in CYP2D6, CYP2C9, CYP2C19, and CYP3A5 on Polypharmacy in Veterans.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 2, p. 390, doi. 10.1002/cpt.3297

By:

Krulikas, Linas;
Bates, Jill;
Chanfreau, Catherine;
Coleman, Heather;
Dalton, Shawn;
Voora, Deepak

Publication type:

Article

Physiologically Based Pharmacokinetic Modeling to Investigate the Disease‐Drug–Drug Interactions between Voriconazole and Nirmatrelvir/Ritonavir in COVID‐19 Patients with CYP2C19 Phenotypes.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 2, p. 363, doi. 10.1002/cpt.3222

By:

Wang, Peile;
Liu, Shuaibing;
Yang, Jing

Publication type:

Article

Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 204, doi. 10.1002/cpt.3270

By:

Böhm, Ruwen;
Bruckmueller, Henrike;
Oswald, Stefan;
Hübenthal, Matthias;
Kaehler, Meike;
Ehmke, Lena;
Höcker, Jan;
Siegmund, Werner;
Franke, Andre;
Cascorbi, Ingolf

Publication type:

Article

Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 5, p. 1141, doi. 10.1002/cpt.3183

By:

Fukui, Rika;
Noda, Satoshi;
Ikeda, Yoshito;
Sawayama, Yuichi;
Terada, Tomohiro;
Nakagawa, Yoshihisa;
Morita, Shin‐ya

Publication type:

Article

Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 5, p. 1033, doi. 10.1002/cpt.3012

By:

Zubiaur, Pablo;
Soria‐Chacartegui, Paula;
Boone, Erin C.;
Prasad, Bhagwat;
Dinh, Jean;
Wang, Wendy Y.;
Zugbi, Santiago;
Rodríguez‐Lopez, Andrea;
González‐Iglesias, Eva;
Leeder, J. Steven;
Abad‐Santos, Francisco;
Gaedigk, Andrea

Publication type:

Article

CYP2C19 Loss‐of‐Function Variants Associated With Long‐Term Ischemic Stroke Events During Clopidogrel Treatment in the Chinese Population.

Published in:

Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 5, p. 1126, doi. 10.1002/cpt.3028

By:

Wu, Peng;
Liu, Ziqing;
Tian, Zijian;
Wu, Benrui;
Shao, Jian;
Li, Qian;
Geng, Zhaoxu;
Pan, Ying;
Lu, Ke;
Wang, Qiang;
Xu, Tao;
Zhou, Kaixin

Publication type:

Article